Rewalk Robotics Ltd - SIC # 3842 - ORTHOPEDIC, PROSTHETIC, AND SURGICAL APPLIANCES AND SUPPLIES

Ticker Exchange SIC # Website Latest Ticker
LFWD Nasdaq 3842 https://golifeward.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rewalk Robotics Ltd

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors - Apr 19th, 2024 12:30 pm
When Will ReWalk Robotics Ltd. (NASDAQ:LFWD) Turn A Profit? - Apr 16th, 2024 10:58 am
Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton - Apr 12th, 2024 12:30 pm
Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate - Apr 1st, 2024 8:30 pm
VA STAND Act introduced in the United States Senate - Mar 22nd, 2024 12:30 pm
Lifeward Announces Reverse Share Split - Mar 13th, 2024 3:45 pm
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy - Mar 8th, 2024 1:30 pm
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered - Mar 1st, 2024 1:45 pm
Analysts Have Made A Financial Statement On ReWalk Robotics Ltd.'s (NASDAQ:LFWD) Annual Report - Mar 1st, 2024 10:16 am
ReWalk Robotics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag - Feb 28th, 2024 11:05 am
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results - Feb 27th, 2024 1:00 pm
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 - Feb 20th, 2024 1:30 pm
7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market - Jan 29th, 2024 1:07 am